Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials

BACKGROUND: The aim of this study was to determine the activity of anthracycline rechallenge using pegylated liposomal doxorubicin (PLD) in patients with metastatic breast cancer (MBC) previously treated with conventional anthracyclines. METHODS: Pooled individual data from four prospective trials w...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Batran, S-E, Güntner, M, Pauligk, C, Scholz, M, Chen, R, Beiss, B, Stopatschinskaja, S, Lerbs, W, Harbeck, N, Jäger, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990592/
https://www.ncbi.nlm.nih.gov/pubmed/20978502
http://dx.doi.org/10.1038/sj.bjc.6605961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990592/
https://www.ncbi.nlm.nih.gov/pubmed/20978502
http://dx.doi.org/10.1038/sj.bjc.6605961

Ejemplares similares